Sarah MacLaughlin
Alberta Health Services
3 Papers
20 Citations
Sarah MacLaughlin is an academic researcher from Alberta Health Services. The author has contributed to research in topics: Breast cancer & Aerobic exercise. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Study design and methods for the Breast Cancer and Exercise Trial in Alberta (BETA)
Christine M. Friedenreich,Christine M. Friedenreich,Sarah MacLaughlin,Heather K. Neilson,Frank Z. Stanczyk,Yutaka Yasui,Aalo Duha,Brigid M. Lynch,Brigid M. Lynch,Ciara Kallal,Kerry S. Courneya +10 more
TL;DR: The BETA Trial will inform future prevention initiatives by assessing adherence to a high volume of exercise over 12 months by postmenopausal women, and the ability of these women to maintain activity over the longer-term, and compare public health guidelines for reducing breast cancer risk through physical activity.
Effects of exercise dose on endogenous estrogens in postmenopausal women: a randomized trial
Christine M. Friedenreich,Heather K. Neilson,Qinggang Wang,Frank Z. Stanczyk,Yutaka Yasui,Aalo Duha,Sarah MacLaughlin,Ciara Kallal,Cynthia C. Forbes,Kerry S. Courneya +9 more
TL;DR: No dose effect was observed for women randomized to 300 vs 150 min/week of moderate to vigorous intensity exercise and the lack of differential effect may be due to modest adherence in the higher dose group.
The Alberta Moving Beyond Breast Cancer (AMBER) Cohort Study: Recruitment, Baseline Assessment, and Description of the First 500 Participants
Kerry S. Courneya,Margaret L. McNeely,S. Nicole Culos-Reed,Jeff K. Vallance,Gordon J. Bell,John R. Mackey,Charles E. Matthews,Andria R. Morielli,Diane Cook,Sarah MacLaughlin,Megan S. Farris,Stephanie Voaklander,Rachel O’Reilly,Christine M. Friedenreich +13 more
TL;DR: AMBER has demonstrated that many newly diagnosed breast cancer survivors are willing and able to complete a wide array of sophisticated and physically demanding HRF and PA assessments soon after diagnosis, which may inform future randomized controlled trials on lifestyle and breast cancer outcomes as well as PA behavior change in breast cancer Survivors.